Ad
related to: unpopular
Search results
Support grows for Erik ten Hag with Manchester United hierarchy still undecided on manager’s future
The Independent via Yahoo Sports· 13 hours agoThe Dutchman won a second trophy in as many years on Saturday when United defeated Man City in the...
Peru’s Unpopular Leader Hits New Low: A 5% Approval Rating
Bloomberg· 15 hours agoPeru’s Dina Boluarte saw her approval rating fall to a new low, with only 5% of people indicating...
Video showing Donald Trump's Bronx rally crowd size goes viral
Newsweek· 2 days agoA video showing former President Donald Trump's crowd size at a rally in New York has gone viral as...
Putin signals he’s open to peace talks, but Ukraine is right to be wary
CNN via Yahoo News· 8 hours agoRussian President Vladimir Putin’s signal that he is open to peace talks should be viewed with vast,...
Review: In Shane Gillis' Netflix show 'Tires,' the humor doesn't veer far from juvenile
Los Angeles Times· 4 days agoGiven that 1) Gillis is popular, if not popular with everyone — unpopular performers don’t host...
Former President Donald Trump is coming to the Coca-Cola 600, and so are Democrats
Durham Herald-Sun via Yahoo News· 2 days agoThe billboards are paid for by the Democratic National Committee, and their messages are consistent...
What’s Your ‘Unpopular Parenting Opinion'? Our Readers Weigh In and We Couldn’t Agree More
Parents via Yahoo News· 4 days agoWe asked our readers to share their 'unpopular parenting opinions,' and these are spot on....
CBS anchor tells Buttigieg Trump is 'not wrong' when it comes to Biden's struggling EV push
Fox News· 10 hours agoTransportation Secretary Pete Buttigieg was confronted by a CBS host over the Biden administration’s...
Democrats will be defending a slim Senate majority in 2024. Here's a look at the states where both...
Business Insider via Yahoo News· 12 hours agoFormer President Donald Trump, who will once again be the Republican presidential nominee this year,...
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 4 days agoBMS is dealing with the loss of patent protection for its cancer medication Revlimid, which it gained through its acquisition of Celgene in 2019. Here's...
